Richard M Epand, Yulia V Shulga, Heath C Timmons, Alexandra L Perri, Jitendra D Belani, Kirishanth Perinpanathan, Laura Beth Johnson-McIntire, Sandra Bajjalieh, Armela O Dicu, Cynthia Elias, Scott D Rychnovsky, Matthew K Topham
Index: Biochemistry 46(49) , 14225-31, (2007)
Full Text: HTML
The alpha, zeta, and epsilon isoforms of diacylglycerol kinase exhibit a high degree of stereospecificity in the phosphorylation of diacylglycerol. In comparison, a multiple lipid kinase, MuLK, shows much less stereospecificity, phosphorylating 1,2-dioleoylglycerol only approximately 2-3 times more rapidly than 2,3-dioleoylglycerol. The alpha and zeta isoforms of diacylglycerol kinase are inhibited by 2,3-dioleoylglycerol, but not the more substrate-selective epsilon isoform. The inhibition by 2,3-dioleoylglycerol is uncompetitive. This corresponds to a kinetic scheme in which the inhibitor can bind to the enzyme-substrate complex, but not to the free enzyme. Our data indicate that despite their similar structures, 1,2-dioleoylglycerol and 2,3-dioleoylglycerol do not compete for the active site of these three isoforms of diacylglycerol kinase. We suggest that the 2,3-dioleoylglycerol binds to a site on the alpha and zeta isoforms of diacylglycerol kinase that is exposed as a consequence of the substrate binding to the active site. The chiral specificity of these enzymes thus mimics the substrate specificity, with MuLK being the least selective and the epsilon isoform of diacylglycerol kinase exhibiting the greatest selectivity.
Structure | Name/CAS No. | Molecular Formula | Articles |
---|---|---|---|
![]() |
Glyceryl Dioleate
CAS:25637-84-7 |
C39H72O5 |
Acid-labile mPEG-vinyl ether-1,2-dioleylglycerol lipids with...
2012-11-05 [Mol. Pharm. 9(11) , 3266-76, (2012)] |
Stability of a liposomal formulation containing lipoyl or di...
2014-12-01 [J. Liposome Res. 24(4) , 304-12, (2014)] |
Defective triglyceride biosynthesis in CETP-deficient SW872 ...
2015-09-01 [J. Lipid Res. 56 , 1669-78, (2015)] |
Identification of a botanical inhibitor of intestinal diacyl...
2015-01-01 [Nutr. Metab. 12 , 27, (2015)] |
Lipid-based liquid crystalline nanoparticles as oral drug de...
2012-01-01 [Int. J. Nanomedicine 7 , 3703-18, (2012)] |
Home | MSDS/SDS Database Search | Journals | Product Classification | Biologically Active Compounds | Selling Leads | About Us | Disclaimer
Copyright © 2024 ChemSrc All Rights Reserved